407 related articles for article (PubMed ID: 34404266)
1. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response.
Hsu PC; Shahed-Al-Mahmud M
Life Sci; 2022 Nov; 308():120981. PubMed ID: 36150465
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
[TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis of the Mechanisms Underlying COVID-19 Modulation of Parkinson's Disease.
Zhang J; Bishir M; Barbhuiya S; Chang SL
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686360
[TBL] [Abstract][Full Text] [Related]
5. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
6. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and neurodegenerative diseases.
Fu YW; Xu HS; Liu SJ
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
[TBL] [Abstract][Full Text] [Related]
8. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
[TBL] [Abstract][Full Text] [Related]
9. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.
Szabo MP; Iba M; Nath A; Masliah E; Kim C
Exp Mol Med; 2022 Apr; 54(4):447-454. PubMed ID: 35396576
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson's Disease.
Angelopoulou E; Karlafti E; Georgakopoulou VE; Papalexis P; Papageorgiou SG; Tegos T; Savopoulos C
Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836893
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).
Zemlin AE; Wiese OJ
Ann Clin Biochem; 2020 Sep; 57(5):339-350. PubMed ID: 32369402
[TBL] [Abstract][Full Text] [Related]
12. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
14. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.
Calderón-Garcidueñas L; Torres-Jardón R; Franco-Lira M; Kulesza R; González-Maciel A; Reynoso-Robles R; Brito-Aguilar R; García-Arreola B; Revueltas-Ficachi P; Barrera-Velázquez JA; García-Alonso G; García-Rojas E; Mukherjee PS; Delgado-Chávez R
J Alzheimers Dis; 2020; 78(2):479-503. PubMed ID: 32955466
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
[TBL] [Abstract][Full Text] [Related]
16. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
18. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's Disease and the COVID-19 Pandemic.
Fearon C; Fasano A
J Parkinsons Dis; 2021; 11(2):431-444. PubMed ID: 33492244
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and its effects on neurological functions.
Yew MMT; Lip JQ; Ling APK
Trop Biomed; 2021 Sep; 38(3):435-445. PubMed ID: 34608117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
